Journal of Viral Hepatitis

Papers
(The H4-Index of Journal of Viral Hepatitis is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Issue Information104
Issue Information32
28
Baseline Alpha‐Fetoprotein Elevation and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B: A Multicentre Cohort Study26
Issue Information24
Persistence of immunity against hepatitis A in Brazilian children vaccinated with a single dose of inactivated virus vaccine23
Clinical Observational Study on HBV Reactivation After Direct‐Acting Antiviral Therapy in HCV / 23
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B22
240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C20
The role of serum sphingolipids as potential biomarkers of non‐response to direct acting antiviral therapy in chronic hepatitis C virus infection20
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐1920
Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England19
Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review19
Hepatitis E Infection in Immunocompromised Patients Previously Treated With Rituximab19
Uptake of the Birth Dose HBV Vaccine and Associated Factors Among Children in Sub‐Saharan Africa: An Analysis Using Recent Demographic and Health Survey Data18
Issue Information18
International disease burden of acute viral hepatitis among adolescents and young adults: An observational study18
A cross‐sectional study of hepatitis C prevalence and correlates among persons who inject drugs in rural and non‐rural communities18
Falling treatment uptake in the hepatitis C care cascade is a growing threat to achieving elimination18
0.11599898338318